Clues to address barriers for access to proton therapy in the Netherlands.

Autor: Thijssen SV; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., Boersma LJ; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., Heising L; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands; Tilburg School of Economics and Management, Tilburg University, Tilburg, the Netherlands., Swart RR; Department of Radiation Oncology (Maastro), GROW School for Oncology and Reproduction, Maastricht University Medical Centre+, Maastricht, the Netherlands., X J Ou C; Tilburg School of Economics and Management, Tilburg University, Tilburg, the Netherlands., Roumen C; Department of Health Services Research, Care and Public Health Research Institute (CAPHRI), Faculty of Health Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands., J G Jacobs M; Tilburg School of Economics and Management, Tilburg University, Tilburg, the Netherlands; Maastro, Maastricht, the Netherlands. Electronic address: maria.jacobs@maastro.nl.

Publikováno v: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2023 Jan; Vol. 178, pp. 109432. Date of Electronic Publication: 2022 Dec 01.